Navigation Links
Obamacare Ruling, Other Pivotal News Rocks Biotech Sector in June
Date:6/28/2012

ATLANTA, June 28, 2012 /PRNewswire-USNewswire/ -- From today's Supreme Court ruling that upholds the Affordable Care Act (ACA) to the FDA's approval of the first new obesity drug in 13 years, June has been a hot month for major news impacting the U.S. biotechnology sector.

(Logo: http://photos.prnewswire.com/prnh/20120628/DC32901LOGO)

Biopharmaceutical drugmakers have held their collective breath wondering what would happen with health care reform and many hesitated to commit resources to implement certain provisions, such as those related to the Physician Payments Sunshine Act, which requires them to report payments made to physicians and teaching hospitals. With this ruling, it's now clear they need to act. The ACA also protects a 12-year marketing exclusivity provision for biologics and upholds a regulatory pathway for biosimilars, which is positive news for biopharmas.

"Bottom line, despite the myriad complexities which biotechs must now weed through, the ACA translates into important business opportunities for biopharmas, not the least of which is a burgeoning biosimilars sub-industry," said Lynn Yoffee, executive editor of BioWorld Today. "Despite over-hanging world economic conditions, biotech is one U.S. business sector that is working. The sector grew by 6.4 percent between 2001-2010 compared to a 2.9 percent decline in overall U.S. private-sector jobs. Twenty-two new biotech drugs have been approved already in 2012, the latest including promising new drugs for breast cancer and obesity. President Obama is poised to sign critical legislation which creates new user fees for generics and biosimilars. And capping off June, the Supreme Court upheld the ACA, yielding both positive and negative ripples."

BioWorld has kept industry insiders abreast of these key stories as they happen, sometimes within minutes. "And we go beyond the breaking news; we provide key perspective on the impact for the drug development sector," Yoffee said.

Check out these top stories from June:

June 28: High Court Upholds ACA: Drugmakers Must Now Implement Provisions

June 28: Belviq Gets FDA Nod; First New Obesity Drug in 13 Years

June 27: Senate Passes PDUFA V; Next Stop: President's Signature

June 12: Perjeta Nod Boosts HER2 Portfolio in Breast Cancer

June 5: T-DM1 Slows Breast Cancer, with Fewer Side Effects

BioWorld is the biopharmaceutical industry's most respected news source and has been so for more than two decades. To subscribe, call (800) 477-6307 or, outside the U.S., (404) 262-5476 or visit www.bioworld.com.


'/>"/>
SOURCE BioWorld
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
3. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
4. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
5. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
6. Middle East and Africa Endoscopy Devices Market Outlook to 2017 - Flexible Endoscopes, Rigid Endoscopes, Endoscopy Visualization Systems, Capsule Endoscope Systems and Others
7. CalHIPSO Enrolls Over 7,700 Providers in EHR Implementation Program, Hits Other Key Milestones After First Two Years
8. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
9. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
10. Clove Oil, a Natural Pesticide Used on Apples and Other Fruit, May Cause Dermatitis
11. Reduction of Chemotherapy and PET-Guided Radiotherapy in Advanced-Stage Hodgkin Lymphoma: the GHSG HD15 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
(Date:9/19/2017)... LOUISVILLE, Ky. , Sept. 19, 2017   ZirMed ... and predictive analytics, today announced that it has been ranked ... the Black Book™ Rankings 2017 User Survey. ZirMed ... software solution for large hospitals and medical centers over 200 ... in Black Book,s healthcare technology user survey history. ...
(Date:9/18/2017)... KALAMAZOO, Mich. , Sept. 18, 2017  PMD ... OptiMed Specialty Pharmacy of Kalamazoo, Mich. ... strategic hub service that expedites and streamlines patient and ... Spiro PD 2.0, and wellness management services.  ... medical device used to measure lung function for a ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... 20, 2017 , ... “The Trials I Face to Receive God’s Grace”: ... his aspirations and goals to better one’s life through God. “The Trials I Face ... in all the wrong places, found a love for writing. Green feels that expressing ...
(Date:9/20/2017)... ... ... “Finn Mouseson”: follows the exciting story of a mouse as the need for ... a journey that will show that friends are to be gathered but home is ... illustrator, Melody Gersonde-Mickelson, who has earned a bachelor’s degree in Fine Arts from the ...
(Date:9/20/2017)... ... September 20, 2017 , ... Ron Norman, CEO ... marketers this week about the value of senior executives, pointed to a quote ... in business has brought us to the present and will lead us into ...
(Date:9/20/2017)... ... ... Moorwick”: the adventures of a young Scottish girl yearning to see the world. “The ... of five who used her time waiting for children to finish their extracurricular activities to ... It was a way to give some meaning to the hours I waited for one ...
(Date:9/20/2017)... ... September 20, 2017 , ... “They Sang At Her ... for a murderer starts revealing the skeletons in their closets. “They Sang At Her ... is now fifty-six years young and married with five children and twelve grandchildren. Before ...
Breaking Medicine News(10 mins):